mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
3e-17 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
5e-15 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
2e-14 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
2e-13 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.28 |
3e-13 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
1e-12 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.26 |
2e-12 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
3e-12 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
4e-12 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
6e-12 |